EMA Issues Q&A on Health-Based Exposure Limits and Prevention of Cross-Contamination

By Sam | April 30, 2018

The European Medicines Agency released Q&A guidance on prevention of cross-contamination and setting health-based exposure limits (HBELs) for risk identification during drug manufacturing in shared facilities.
Source: Drug Industry Daily

Posted in Drug Industry Daily